MolDX: Guardant360 Plasma-Based Comprehensive Genomic Profiling in Solid Tumors Proposed LCD Retirement - Effective May 13, 2020
This proposed Local Coverage Determination (LCD) has been retired under contractor 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number: DL38127
LCD Title: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Solid Tumors
Effective Date: May 13, 2020
Rationale: In order to provide a more generic, non-proprietary coverage for plasma based genomic profiling, Noridian is retiring this proposed LCD.
To access retired proposed LCDs, visit the CMS Medicare Coverage Database Archive.
Last Updated May 15, 2020